TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

Point72 Asset Management, L.P.'s Holding History (CIK: 0001603466)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,000,000 Value ($000) $5,695 Avg Close — Range —
Q3 2025
Shares 10,000,000 Value ($000) $11,348 Avg Close — Range —
Q1 2025
Shares 7,995,000 Value ($000) $8,009 Avg Close — Range —
Q4 2024
Shares 14,995,000 Value ($000) $14,111 Avg Close — Range —
Q3 2024
Shares 8,495,000 Value ($000) $7,361 Avg Close — Range —
Q2 2024
Shares 4,495,000 Value ($000) $2,981 Avg Close — Range —
Q1 2024
Shares 2,557,000 Value ($000) $1,622 Avg Close — Range —
Q4 2023
Shares 2,557,000 Value ($000) $1,676 Avg Close — Range —
Q3 2023
Shares 2,557,000 Value ($000) $1,655 Avg Close — Range —
Q2 2023
Shares 8,557,000 Value ($000) $6,938 Avg Close — Range —
Q1 2023
Shares 8,500,000 Value ($000) $8,365 Avg Close — Range —
Q3 2022
Shares 4,000,000 Value ($000) $4,079 Avg Close — Range —
Q2 2022
Shares 4,000,000 Value ($000) $4,027 Avg Close — Range —
Q1 2022
Shares 4,000,000 Value ($000) $4,260 Avg Close — Range —